Biomarker Panel
Cross-source consensus on Biomarker Panel from 1 sources and 4 claims.
1 sources · 4 claims
Preparation
Evidence quality
Other
Highlighted claims
- Before feature selection, lymphocytes and eGFR were removed from modelling to satisfy the local independence assumption for latent class analysis. — Exploring a panel of serum biomarkers for cancer risk in patients with non-specific symptoms: a comparative analysis of feature selection methods
- The study assessed a comprehensive serum biomarker panel from blood samples collected at the first RDC consultation. — Exploring a panel of serum biomarkers for cancer risk in patients with non-specific symptoms: a comparative analysis of feature selection methods
- The biomarker panel included blood count, metabolic, hepatic, inflammatory, tumour-associated, light-chain, and derived ratio measures. — Exploring a panel of serum biomarkers for cancer risk in patients with non-specific symptoms: a comparative analysis of feature selection methods
- High collinearity was observed among lymphocytes, leukocytes, NLR, and renal biomarkers before feature selection. — Exploring a panel of serum biomarkers for cancer risk in patients with non-specific symptoms: a comparative analysis of feature selection methods